Evaluation of the Potential of Endorectal MRI for the Staging and Recurrence of Prostate Cancer
- Age of patients: up to 80 years.
- Men scheduled for radical prostatectomy due to prostate cancer or men post radical
prostatectomy with suspicion of recurrence.
- Patients who are able and willing to give consent and able to have an MRI
- Contraindications to MRI including: claustrophobia, weight over 120 kg, implanted
ferromagnetic materials or foreign objects, and known intolerance to the MRI contrast
agent (e.g. Gadolinium or Dotarem)
- Individuals who are not able or willing to tolerate the required prolonged stationary
supine position during imaging (approximately 1 hr.)
- Any rectal pathology preventing probe insertion, (as active proctitis, active
ulcerative colitis, fissure ani)
- Any spinal pathology that prohibits maintaining supine position for an hour
- Patients with documented myocardial infarction within one month of protocol entry,
and patients with cardiac pacemakers
- Severe cerebrovascular disease (multiple CVA or CVA within 6 months)